Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991. (13th August 2013)

• Record Type: Journal Article
• Authors: Holterhues, C.; Hollestein, L.M.; Nijsten, T.; Koomen, E.R.; Nusselder, W.; de, E.
• Is Part Of: British journal of dermatology. Volume 169:Number 2(2013:Aug.)
• Page Start: 389
• Page End: 397
• Publication Date: 2013-08-13
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.12346
• Languages: English
• ISSNs: 0007-0963

Abstract

<abstract abstract-type="short" xml:lang="en" id="bjd12346-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>What's already known about this topic?</bold> </p> <p> <list id="bjd12346-list-0001" list-type="bullet"> <list-item> <p>Melanoma leads to a loss of 20 years of life during a lifetime.</p> </list-item> </list> </p> <p> <bold>What does this study add?</bold> </p> <p> <list id="bjd12346-list-0002" list-type="bullet"> <list-item> <p>Both the fatal and nonfatal burden of melanoma are important to describe the impact on society, because patients live on average 19–27 years with melanoma.</p> </list-item> <list-item> <p>The burden of melanoma has increased rapidly, now exceeding 21 000 disability‐adjusted life‐years annually.</p> </list-item> <list-item> <p>There is a general need for an empirical estimation of disability weights and duration of disease.</p> </list-item> </list> </p> </abstract>